Tapewire

NYSE · USD

NUS

NU SKIN ENTERPRISES, INC.

Export transactions ↓
Tapewire entity
6223
SEC CIK
0001021561
Parsed reports
476

Last 12 months

Inside the activity.

1 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202602
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2022 Filed Feb 18, 2022 02:37 UTC
Lawrence Mark HChief Financial Officer
Tax withholdingClass A Common Stock 5,139 $49.65 $255,151.35
Disclosure

SEC source: 0001062993-22-004840 · form4.xml · nonDerivative · entry 1

Lawrence Mark H · CIK 0001701170 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,705

F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Read SEC document
February 15, 2022 Filed Feb 18, 2022 02:36 UTC
NAPIERSKI RYAN SPresident and CEO
Tax withholdingClass A Common Stock 4,498 $49.65 $223,325.70
Disclosure

SEC source: 0001062993-22-004838 · form4.xml · nonDerivative · entry 1

NAPIERSKI RYAN S · CIK 0001652984 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,070

F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:43 UTC
Thomas James DChief Accounting Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 2,710 $0.00 Strike: $48.81 $0.00
Disclosure

SEC source: 0001062993-22-004465 · form4.xml · derivative · entry 2

Thomas James D · CIK 0001784360 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,710

Underlying: Class A Common Stock · 2,710 shares

Expires 2028-02-15

F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:43 UTC
Thomas James DChief Accounting Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 9,002 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001062993-22-004465 · form4.xml · derivative · entry 1

Thomas James D · CIK 0001784360 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,002

Underlying: Class A Common Stock · 9,002 shares

Expires 2027-02-15

F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:44 UTC
Hatchett Steven KeithChief Product Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 4,879 $0.00 Strike: $48.81 $0.00
Disclosure

SEC source: 0001062993-22-004466 · form4.xml · derivative · entry 2

Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,879

Underlying: Class A Common Stock · 4,879 shares

Expires 2028-02-15

F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:44 UTC
Hatchett Steven KeithChief Product Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 10,554 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001062993-22-004466 · form4.xml · derivative · entry 1

Hatchett Steven Keith · CIK 0001880182 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,108

Underlying: Class A Common Stock · 10,554 shares

Expires 2027-02-15

F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:42 UTC
Clark Chayce DavidEVP and General Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 3,118 $0.00 Strike: $53.69 $0.00
Disclosure

SEC source: 0001062993-22-004464 · form4.xml · derivative · entry 3

Clark Chayce David · CIK 0001873048 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,118

Underlying: Class A Common Stock · 3,118 shares

Expires 2028-08-01

F3 · shares: On August 1, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:42 UTC
Clark Chayce DavidEVP and General Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 1,431 $0.00 Strike: $48.81 $0.00
Disclosure

SEC source: 0001062993-22-004464 · form4.xml · derivative · entry 2

Clark Chayce David · CIK 0001873048 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,431

Underlying: Class A Common Stock · 1,431 shares

Expires 2028-02-15

F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:42 UTC
Clark Chayce DavidEVP and General Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 4,390 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001062993-22-004464 · form4.xml · derivative · entry 1

Clark Chayce David · CIK 0001873048 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,390

Underlying: Class A Common Stock · 4,390 shares

Expires 2027-02-15

F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:41 UTC
CHANG JOSEPH YChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 10,840 $0.00 Strike: $48.81 $0.00
Disclosure

SEC source: 0001062993-22-004463 · form4.xml · derivative · entry 2

CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,840

Underlying: Class A Common Stock · 10,840 shares

Expires 2028-02-15

F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:41 UTC
CHANG JOSEPH YChief Scientific Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 33,060 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001062993-22-004463 · form4.xml · derivative · entry 1

CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,118

Underlying: Class A Common Stock · 33,060 shares

Expires 2027-02-15

F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:39 UTC
Lawrence Mark HChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 14,906 $0.00 Strike: $48.81 $0.00
Disclosure

SEC source: 0001062993-22-004462 · form4.xml · derivative · entry 2

Lawrence Mark H · CIK 0001701170 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,906

Underlying: Class A Common Stock · 14,906 shares

Expires 2028-02-15

F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:39 UTC
Lawrence Mark HChief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 46,560 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001062993-22-004462 · form4.xml · derivative · entry 1

Lawrence Mark H · CIK 0001701170 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,122

Underlying: Class A Common Stock · 46,560 shares

Expires 2027-02-15

F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:38 UTC
NAPIERSKI RYAN SPresident and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 21,883 $0.00 Strike: $48.81 $0.00
Disclosure

SEC source: 0001062993-22-004461 · form4.xml · derivative · entry 2

NAPIERSKI RYAN S · CIK 0001652984 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,883

Underlying: Class A Common Stock · 21,883 shares

Expires 2028-02-15

F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.

Read SEC document
February 11, 2022 Filed Feb 15, 2022 21:38 UTC
NAPIERSKI RYAN SPresident and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 70,540 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001062993-22-004461 · form4.xml · derivative · entry 1

NAPIERSKI RYAN S · CIK 0001652984 · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,080

Underlying: Class A Common Stock · 70,540 shares

Expires 2027-02-15

F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above.

Read SEC document
January 24, 2022 Filed Jan 24, 2022 23:24 UTC SaleClass A Common Stock 1,000 $50.50 $50,500.00
Disclosure

SEC source: 0001062993-22-001489 · form4.xml · nonDerivative · entry 1

LIPMAN ANDREW D · CIK 0001184208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,214

F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person.

Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:26 UTC GrantClass A Common Stock 12 $46.19 $554.28
Disclosure

SEC source: 0001062993-21-012458 · form4.xml · nonDerivative · entry 1

WOODBURY EDWINA D · CIK 0001051405 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,476

F1 · shares: These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

Read SEC document
November 11, 2021 Filed Feb 2, 2022 21:50 UTC
LUND STEVENDirector · Exec. Chairman of the Board
GiftClass A Common Stock 24,183 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-002234 · form5.xml · nonDerivative · entry 1

LUND STEVEN · CIK 0001033942 · Director · Exec. Chairman of the Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By SJL NS-Holdings L.L.C.

Disclosed balance after: 216,509

F1 · ownership.nature: SJL NS-Holdings is a family limited liability company which is owned and controlled by the Reporting Person and his immediate family.

Read SEC document
November 02, 2021 Filed Feb 2, 2022 21:47 UTC GiftClass A Common Stock 76,766 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-002230 · form5.xml · nonDerivative · entry 2

CAMPBELL DANIEL W · CIK 0001184200 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By an irrevocable family trust

Disclosed balance after: 76,766

F1 · kind: The Reporting Person transferred these shares to an irrevocable family trust for which the Reporting Person's spouse serves as a trustee. The beneficiaries of this trust include the Reporting Person and certain of his family members.

Read SEC document
November 02, 2021 Filed Feb 2, 2022 21:47 UTC GiftClass A Common Stock 76,766 $0.00 $0.00
Disclosure

SEC source: 0001062993-22-002230 · form5.xml · nonDerivative · entry 1

CAMPBELL DANIEL W · CIK 0001184200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,513

F1 · kind: The Reporting Person transferred these shares to an irrevocable family trust for which the Reporting Person's spouse serves as a trustee. The beneficiaries of this trust include the Reporting Person and certain of his family members.

Read SEC document
October 05, 2021 Filed Oct 5, 2021 22:21 UTC
Bettinger Jeffrey ClarkSVP, People and Places Officer
SaleClass A Common Stock 1,625 $41.10 $66,787.50
Disclosure

SEC source: 0001062993-21-009238 · form4.xml · nonDerivative · entry 2

Bettinger Jeffrey Clark · CIK 0001880295 · SVP, People and Places Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,068

F2 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.80 to $41.33, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
October 01, 2021 Filed Oct 5, 2021 22:21 UTC
Bettinger Jeffrey ClarkSVP, People and Places Officer
Tax withholdingClass A Common Stock 1,498 $41.48 $62,137.04
Disclosure

SEC source: 0001062993-21-009238 · form4.xml · nonDerivative · entry 1

Bettinger Jeffrey Clark · CIK 0001880295 · SVP, People and Places Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,693

F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.

Read SEC document
September 13, 2021 Filed Sep 13, 2021 21:50 UTC
CHANG JOSEPH YEVP, Chief Scientific Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 16,000 $0.00 Strike: $30.63 $0.00
Disclosure

SEC source: 0001062993-21-008532 · form4.xml · derivative · entry 4

CHANG JOSEPH Y · CIK 0001184201 · EVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,600

Underlying: Class A Common Stock · 16,000 shares

Expires 2023-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Currently exercisable in full.

Read SEC document
September 13, 2021 Filed Sep 13, 2021 21:50 UTC
CHANG JOSEPH YEVP, Chief Scientific Officer
SaleClass A Common Stock 16,000 $47.41 $758,560.00
Disclosure

SEC source: 0001062993-21-008532 · form4.xml · nonDerivative · entry 2

CHANG JOSEPH Y · CIK 0001184201 · EVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,942

F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.15 to $47.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
September 13, 2021 Filed Sep 13, 2021 21:50 UTC
CHANG JOSEPH YEVP, Chief Scientific Officer
Exercise / conversionClass A Common Stock 16,000 $30.63 $490,080.00
Disclosure

SEC source: 0001062993-21-008532 · form4.xml · nonDerivative · entry 1

CHANG JOSEPH Y · CIK 0001184201 · EVP, Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,942

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 08, 2021 Filed Sep 8, 2021 21:41 UTC GrantClass A Common Stock 11 $49.54 $544.94
Disclosure

SEC source: 0001062993-21-008392 · form4.xml · nonDerivative · entry 1

WOODBURY EDWINA D · CIK 0001051405 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,464

F1 · shares: These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

Read SEC document
September 01, 2021 Filed Sep 1, 2021 21:07 UTC
NAPIERSKI RYAN SDirector · President and CEO
GrantClass A Common Stock 13,707 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-008101 · form4.xml · nonDerivative · entry 1

NAPIERSKI RYAN S · CIK 0001652984 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,568

Read SEC document
August 01, 2021 Filed Aug 2, 2021 21:50 UTC
Clark Chayce DavidEVP and General Counsel
GrantClass A Common Stock 1,863 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000127 · edgar.xml · nonDerivative · entry 1

Clark Chayce David · CIK 0001873048 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,976

Read SEC document
July 02, 2021 Filed Jul 6, 2021 23:05 UTC
DORNY D MATTHEWGeneral Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,200 $0.00 Strike: $30.63 $0.00
Disclosure

SEC source: 0001021561-21-000123 · edgar.xml · derivative · entry 4

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,600

Underlying: Class A Common Stock · 6,200 shares

Expires 2023-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Currently exercisable in full.

Read SEC document
July 02, 2021 Filed Jul 6, 2021 23:05 UTC
DORNY D MATTHEWGeneral Counsel
SaleClass A Common Stock 200 $57.30 $11,460.00
Disclosure

SEC source: 0001021561-21-000123 · edgar.xml · nonDerivative · entry 3

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,159

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.29 to $57.31, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
July 02, 2021 Filed Jul 6, 2021 23:05 UTC
DORNY D MATTHEWGeneral Counsel
SaleClass A Common Stock 6,000 $56.87 $341,220.00
Disclosure

SEC source: 0001021561-21-000123 · edgar.xml · nonDerivative · entry 2

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,359

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.27 to $57.25, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
July 02, 2021 Filed Jul 6, 2021 23:05 UTC
DORNY D MATTHEWGeneral Counsel
Exercise / conversionClass A Common Stock 6,200 $30.63 $189,906.00
Disclosure

SEC source: 0001021561-21-000123 · edgar.xml · nonDerivative · entry 1

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 21:19 UTC
WOOD RITCH NChief Executive Officer
SaleClass A Common Stock 1,902 $57.94 $110,201.88
Disclosure

SEC source: 0001021561-21-000121 · edgar.xml · nonDerivative · entry 4

WOOD RITCH N · CIK 0001184211 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 175,239

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.64 to $58.50, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 21:19 UTC
WOOD RITCH NChief Executive Officer
SaleClass A Common Stock 16,348 $57.08 $933,143.84
Disclosure

SEC source: 0001021561-21-000121 · edgar.xml · nonDerivative · entry 3

WOOD RITCH N · CIK 0001184211 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,141

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.63 to $57.62, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 21:19 UTC
WOOD RITCH NChief Executive Officer
SaleClass A Common Stock 3,036 $59.40 $180,338.40
Disclosure

SEC source: 0001021561-21-000121 · edgar.xml · nonDerivative · entry 2

WOOD RITCH N · CIK 0001184211 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,489

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.23 to $59.59, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 21:19 UTC
WOOD RITCH NChief Executive Officer
SaleClass A Common Stock 15,214 $58.74 $893,670.36
Disclosure

SEC source: 0001021561-21-000121 · edgar.xml · nonDerivative · entry 1

WOOD RITCH N · CIK 0001184211 · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,525

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.23 to $59.22, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
June 09, 2021 Filed Jun 9, 2021 22:16 UTC GrantClass A Common Stock 9 $62.44 $561.96
Disclosure

SEC source: 0001021561-21-000119 · edgar.xml · nonDerivative · entry 1

WOODBURY EDWINA D · CIK 0001051405 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,453

F1 · shares: These shares were acquired through a dividend reinvestment under the Company's Deferred Compensation Plan in accordance with the Plan's terms.

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:18 UTC GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000117 · edgar.xml · nonDerivative · entry 1

WOODBURY EDWINA D · CIK 0001051405 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,444

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:14 UTC
Shen ZheqingDirector
GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000115 · edgar.xml · nonDerivative · entry 1

Shen Zheqing · CIK 0001681867 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,454

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:12 UTC GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000113 · edgar.xml · nonDerivative · entry 1

Thomas Pisano R. · CIK 0001436785 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,435

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:09 UTC GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000111 · edgar.xml · nonDerivative · entry 1

Nathanson Laura · CIK 0001778431 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,957

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:07 UTC GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000109 · edgar.xml · nonDerivative · entry 1

LIPMAN ANDREW D · CIK 0001184208 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,214

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:03 UTC GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000107 · edgar.xml · nonDerivative · entry 1

CAMPBELL DANIEL W · CIK 0001184200 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,279

Read SEC document
June 02, 2021 Filed Jun 2, 2021 22:00 UTC GrantClass A Common Stock 2,467 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000105 · edgar.xml · nonDerivative · entry 1

Battle Emma S. · CIK 0001769744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,467

Read SEC document
June 01, 2021 Filed Jun 2, 2021 21:48 UTC
DORNY D MATTHEWGeneral Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,200 $0.00 Strike: $30.63 $0.00
Disclosure

SEC source: 0001021561-21-000100 · edgar.xml · derivative · entry 3

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,800

Underlying: Class A Common Stock · 6,200 shares

Expires 2023-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Currently exercisable in full.

Read SEC document
June 01, 2021 Filed Jun 2, 2021 21:48 UTC
DORNY D MATTHEWGeneral Counsel
SaleClass A Common Stock 6,200 $60.78 $376,836.00
Disclosure

SEC source: 0001021561-21-000100 · edgar.xml · nonDerivative · entry 2

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,159

F1 · shares: Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.27 to $61.04, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

Read SEC document
June 01, 2021 Filed Jun 2, 2021 21:48 UTC
DORNY D MATTHEWGeneral Counsel
Exercise / conversionClass A Common Stock 6,200 $30.63 $189,906.00
Disclosure

SEC source: 0001021561-21-000100 · edgar.xml · nonDerivative · entry 1

DORNY D MATTHEW · CIK 0001231132 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,359

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2021 Filed May 24, 2021 21:17 UTC
Thomas James DChief Accounting Officer
GiftClass A Common Stock 677 $0.00 $0.00
Disclosure

SEC source: 0001021561-21-000093 · edgar.xml · nonDerivative · entry 3

Thomas James D · CIK 0001784360 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,566

Read SEC document
May 21, 2021 Filed May 24, 2021 21:17 UTC
Thomas James DChief Accounting Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 9,002 $0.00 Strike: $30.45 $0.00
Disclosure

SEC source: 0001021561-21-000093 · edgar.xml · derivative · entry 4

Thomas James D · CIK 0001784360 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 9,002 shares

Expires 2027-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Currently exercisable in full.

Read SEC document
May 21, 2021 Filed May 24, 2021 21:17 UTC
Thomas James DChief Accounting Officer
SaleClass A Common Stock 10,619 $60.00 $637,140.00
Disclosure

SEC source: 0001021561-21-000093 · edgar.xml · nonDerivative · entry 2

Thomas James D · CIK 0001784360 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,243

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.